US Stock MarketDetailed Quotes

TELA TELA Bio

Watchlist
  • 2.770
  • -0.070-2.46%
Close Dec 13 16:00 ET
  • 2.770
  • 0.0000.00%
Post 20:01 ET
109.11MMarket Cap-1.64P/E (TTM)

TELA Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-28.92%-8.98M
5.03%-10.7M
-24.28%-14.38M
-0.27%-40.86M
-0.62%-11.05M
8.90%-6.97M
3.61%-11.26M
-10.97%-11.57M
-33.90%-40.75M
-14.55%-10.98M
Net income from continuing operations
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
-2.27%-10.96M
15.31%-10.79M
-10.73%-12.03M
-33.12%-44.3M
-15.78%-9.98M
Operating gains losses
--0
--0
---7.58M
-119.90%-328K
----
----
----
----
11,671.43%1.65M
-3,330.00%-343K
Depreciation and amortization
20.64%263K
16.36%249K
8.84%234K
-31.93%808K
-22.22%161K
6.34%218K
-65.54%214K
39.61%215K
121.87%1.19M
51.09%207K
Other non cash items
261.57%875K
78.87%474K
-3.37%689K
-21.03%1.96M
277.66%744K
-67.95%242K
-49.04%265K
-29.75%713K
18.26%2.49M
-29.89%197K
Change In working capital
-138.43%-830K
104.01%90K
-97.63%-3.17M
71.04%-1.67M
101.00%21K
200.84%2.16M
14.82%-2.25M
7.82%-1.6M
-66.13%-5.76M
4.32%-2.1M
-Change in receivables
-747.26%-2.01M
141.38%497K
-1,200.00%-234K
-26.31%-3.06M
-80.00%-1.6M
43.03%-237K
-16.60%-1.2M
78.82%-18K
-55.89%-2.42M
-35.46%-890K
-Change in inventory
-43.03%-811K
-112.45%-115K
62.95%-1.43M
55.24%-2.72M
68.09%785K
77.79%-567K
291.70%924K
-10.13%-3.86M
-16.92%-6.07M
131.28%467K
-Change in prepaid assets
6.69%271K
22.34%-226K
20.35%479K
-106.66%-81K
-316.98%-442K
-36.82%254K
-168.79%-291K
-19.92%398K
222.58%1.22M
90.96%-106K
-Change in payables and accrued expense
-27.91%1.7M
94.80%-74K
-199.39%-1.96M
176.44%4.19M
181.27%1.28M
-28.13%2.36M
8.07%-1.42M
45.57%1.97M
-64.52%1.52M
-240.25%-1.58M
-Change in other working capital
----
103.14%8K
74.47%-24K
----
----
----
---255K
---94K
----
----
Cash from discontinued investing activities
Operating cash flow
-28.92%-8.98M
5.03%-10.7M
-24.28%-14.38M
-0.27%-40.86M
-0.62%-11.05M
8.90%-6.97M
3.61%-11.26M
-10.97%-11.57M
-33.90%-40.75M
-14.55%-10.98M
Investing cash flow
Cash flow from continuing investing activities
8.96%-122K
142.68%67K
4,183.48%4.7M
68.00%-599K
81.55%-193K
53.79%-134K
21.50%-157K
65.77%-115K
-198.56%-1.87M
-261.94%-1.05M
Net PPE purchase and sale
8.96%-122K
-90.45%-299K
-164.35%-304K
31.31%-599K
-319.57%-193K
53.79%-134K
21.50%-157K
65.77%-115K
-39.07%-872K
84.08%-46K
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
---1M
----
Net other investing changes
--0
--366K
--5M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
8.96%-122K
142.68%67K
4,183.48%4.7M
68.00%-599K
81.55%-193K
53.79%-134K
21.50%-157K
65.77%-115K
-198.56%-1.87M
-261.94%-1.05M
Financing cash flow
Cash flow from continuing financing activities
38.03%98K
-100.01%-5K
123.83%56K
13.26%46.27M
110.05%22K
-99.79%71K
598.09%46.41M
-60.96%-235K
6,883.25%40.85M
-225.86%-219K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--10M
--0
Net common stock issuance
--0
----
----
34.71%46.34M
--0
-100.04%-13K
----
----
--34.4M
---275K
Proceeds from stock option exercised by employees
31.46%117K
-89.29%6K
772.73%384K
211.59%215K
-53.57%26K
8,800.00%89K
1,020.00%56K
528.57%44K
-88.21%69K
-67.82%56K
Net other financing activities
-280.00%-19K
-1,000.00%-11K
-17.56%-328K
92.01%-289K
---4K
95.33%-5K
99.97%-1K
-82.35%-279K
---3.62M
--0
Cash from discontinued financing activities
Financing cash flow
38.03%98K
-100.01%-5K
123.83%56K
13.26%46.27M
110.05%22K
-99.79%71K
598.09%46.41M
-60.96%-235K
6,883.25%40.85M
-225.86%-219K
Net cash flow
Beginning cash position
-59.00%26.76M
24.18%37.41M
11.84%46.99M
-4.35%42.02M
7.33%58.2M
135.40%65.27M
-8.76%30.12M
-4.35%42.02M
-40.95%43.93M
1.10%54.23M
Current changes in cash
-28.10%-9.01M
-130.40%-10.64M
19.22%-9.63M
372.12%4.81M
8.38%-11.22M
-126.40%-7.03M
767.96%34.99M
-9.27%-11.92M
94.20%-1.77M
-26.23%-12.25M
Effect of exchange rate changes
-469.70%-188K
-107.79%-12K
58.62%46K
213.89%164K
-65.85%14K
74.42%-33K
390.57%154K
1,066.67%29K
-1,409.09%-144K
2,150.00%41K
End cash Position
-69.82%17.57M
-59.00%26.76M
24.18%37.41M
11.84%46.99M
11.84%46.99M
7.33%58.2M
135.40%65.27M
-8.76%30.12M
-4.35%42.02M
-4.35%42.02M
Free cash flow
-28.20%-9.11M
3.72%-11M
-25.66%-14.69M
2.70%-41.47M
6.43%-11.26M
10.54%-7.1M
3.91%-11.42M
-8.57%-11.69M
-37.22%-42.62M
-21.79%-12.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -28.92%-8.98M5.03%-10.7M-24.28%-14.38M-0.27%-40.86M-0.62%-11.05M8.90%-6.97M3.61%-11.26M-10.97%-11.57M-33.90%-40.75M-14.55%-10.98M
Net income from continuing operations 5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M-2.27%-10.96M15.31%-10.79M-10.73%-12.03M-33.12%-44.3M-15.78%-9.98M
Operating gains losses --0--0---7.58M-119.90%-328K----------------11,671.43%1.65M-3,330.00%-343K
Depreciation and amortization 20.64%263K16.36%249K8.84%234K-31.93%808K-22.22%161K6.34%218K-65.54%214K39.61%215K121.87%1.19M51.09%207K
Other non cash items 261.57%875K78.87%474K-3.37%689K-21.03%1.96M277.66%744K-67.95%242K-49.04%265K-29.75%713K18.26%2.49M-29.89%197K
Change In working capital -138.43%-830K104.01%90K-97.63%-3.17M71.04%-1.67M101.00%21K200.84%2.16M14.82%-2.25M7.82%-1.6M-66.13%-5.76M4.32%-2.1M
-Change in receivables -747.26%-2.01M141.38%497K-1,200.00%-234K-26.31%-3.06M-80.00%-1.6M43.03%-237K-16.60%-1.2M78.82%-18K-55.89%-2.42M-35.46%-890K
-Change in inventory -43.03%-811K-112.45%-115K62.95%-1.43M55.24%-2.72M68.09%785K77.79%-567K291.70%924K-10.13%-3.86M-16.92%-6.07M131.28%467K
-Change in prepaid assets 6.69%271K22.34%-226K20.35%479K-106.66%-81K-316.98%-442K-36.82%254K-168.79%-291K-19.92%398K222.58%1.22M90.96%-106K
-Change in payables and accrued expense -27.91%1.7M94.80%-74K-199.39%-1.96M176.44%4.19M181.27%1.28M-28.13%2.36M8.07%-1.42M45.57%1.97M-64.52%1.52M-240.25%-1.58M
-Change in other working capital ----103.14%8K74.47%-24K---------------255K---94K--------
Cash from discontinued investing activities
Operating cash flow -28.92%-8.98M5.03%-10.7M-24.28%-14.38M-0.27%-40.86M-0.62%-11.05M8.90%-6.97M3.61%-11.26M-10.97%-11.57M-33.90%-40.75M-14.55%-10.98M
Investing cash flow
Cash flow from continuing investing activities 8.96%-122K142.68%67K4,183.48%4.7M68.00%-599K81.55%-193K53.79%-134K21.50%-157K65.77%-115K-198.56%-1.87M-261.94%-1.05M
Net PPE purchase and sale 8.96%-122K-90.45%-299K-164.35%-304K31.31%-599K-319.57%-193K53.79%-134K21.50%-157K65.77%-115K-39.07%-872K84.08%-46K
Net intangibles purchase and sale --------------0-------------------1M----
Net other investing changes --0--366K--5M----------------------------
Cash from discontinued investing activities
Investing cash flow 8.96%-122K142.68%67K4,183.48%4.7M68.00%-599K81.55%-193K53.79%-134K21.50%-157K65.77%-115K-198.56%-1.87M-261.94%-1.05M
Financing cash flow
Cash flow from continuing financing activities 38.03%98K-100.01%-5K123.83%56K13.26%46.27M110.05%22K-99.79%71K598.09%46.41M-60.96%-235K6,883.25%40.85M-225.86%-219K
Net issuance payments of debt --------------0------------------10M--0
Net common stock issuance --0--------34.71%46.34M--0-100.04%-13K----------34.4M---275K
Proceeds from stock option exercised by employees 31.46%117K-89.29%6K772.73%384K211.59%215K-53.57%26K8,800.00%89K1,020.00%56K528.57%44K-88.21%69K-67.82%56K
Net other financing activities -280.00%-19K-1,000.00%-11K-17.56%-328K92.01%-289K---4K95.33%-5K99.97%-1K-82.35%-279K---3.62M--0
Cash from discontinued financing activities
Financing cash flow 38.03%98K-100.01%-5K123.83%56K13.26%46.27M110.05%22K-99.79%71K598.09%46.41M-60.96%-235K6,883.25%40.85M-225.86%-219K
Net cash flow
Beginning cash position -59.00%26.76M24.18%37.41M11.84%46.99M-4.35%42.02M7.33%58.2M135.40%65.27M-8.76%30.12M-4.35%42.02M-40.95%43.93M1.10%54.23M
Current changes in cash -28.10%-9.01M-130.40%-10.64M19.22%-9.63M372.12%4.81M8.38%-11.22M-126.40%-7.03M767.96%34.99M-9.27%-11.92M94.20%-1.77M-26.23%-12.25M
Effect of exchange rate changes -469.70%-188K-107.79%-12K58.62%46K213.89%164K-65.85%14K74.42%-33K390.57%154K1,066.67%29K-1,409.09%-144K2,150.00%41K
End cash Position -69.82%17.57M-59.00%26.76M24.18%37.41M11.84%46.99M11.84%46.99M7.33%58.2M135.40%65.27M-8.76%30.12M-4.35%42.02M-4.35%42.02M
Free cash flow -28.20%-9.11M3.72%-11M-25.66%-14.69M2.70%-41.47M6.43%-11.26M10.54%-7.1M3.91%-11.42M-8.57%-11.69M-37.22%-42.62M-21.79%-12.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List